{"schema_version":"secwatch.filing_event.v1","accession":"0001770787-25-000011","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.799746+00:00","generated_at":"2026-05-26T22:57:50.050183+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"10x Genomics Q4 revenue down 10% YoY to $165M; FY2024 net loss $182.6M; guidance ~flat","bullets":["Q4 2024 revenue $165.0M (-10% YoY); full year $610.8M (-1% YoY).","Q4 operating loss $49.8M, net loss $49.0M (unchanged YoY).","Full year 2024 net loss $182.6M, improved from $255.1M loss in 2023.","FY2025 revenue guidance $610M-$630M (0-3% growth); midpoint implies double-digit growth for Chromium and spatial.","Cash and securities $393.4M; launched Billion Cells Project with CZI and Ultima Genomics."],"urls":{"canonical":"https://secwatch.observer/filing/0001770787-25-000011","json":"https://secwatch.observer/filing/0001770787-25-000011.json","markdown":"https://secwatch.observer/filing/0001770787-25-000011.md","text":"https://secwatch.observer/filing/0001770787-25-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000177078725000011/0001770787-25-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000177078725000011/txg-20250212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:57:50.050183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}